EDX Medical Group become a Founding Partner

EDX Medical Group plc, a leading UK-based medical diagnostics company founded by Professor Sir Chris Evans, has been welcomed as a Founding Partner of the Cancer Awareness Trust. EDX Medical is a pioneer in the development and provision of advanced diagnostic technologies for personalised treatment of cancer, cardiovascular and infectious diseases Renowned for its innovation in cancer diagnostics, EDX Medical offers its expertise and support towards our fundraising goals to help develop Cancer Platform and transform cancer outcomes for all.

Professor Sir Chris Evans, founder of both EDX Medical Group plc and the Cancer Awareness Trust, highlighted the strong alignment between the two organisations’ missions.

Professor Sir Chris Evans, OBE, Founder of EDX Medical said: “I am proud to see my company supporting the brilliant work of Cancer Awareness Trust. Both organisations are committed to improving early diagnosis and accelerating the adoption of personalised treatments. Together, we have the potential to help save millions of lives.”

Mike Zatyka, Global Fundraising Director of Cancer Awareness Trust, said: “From day one, Sir Chris made it clear that his new ventures would align with our values and mission. EDX Medical becoming a Founding Partner of Cancer Awareness Trust is testament to that commitment. This support, both in expertise and funding, will ignite the next stage of our journey to transform cancer outcomes for everyone.”